Taysha Gene Therapies Price Target Maintained With a $11.00/Share by Citizens
DO Dow Jones Newswires Taysha Gene Therapies Price Target Maintained With a $11.00/Share by Citizens 7/2/2026, 09:06 PM GMT+8 Dow Jones Newswires TS TSHA Taysha Gene Therapies Price Target Maintained With a $11.00/Share by Citizens Market News Dow Jones Newswires Taysha Gene Therapies Is Maintained at Buy by Needham Dow Jones Newswires Taysha Gene Therapies Is Maintained at Outperform by Baird TradingView Taysha Gene Therapies, Inc. Stock 12‑Month Price Target Raised to $13, Implies 105% Upside
